http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02076174-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df5016d32b888add7211643738680620 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e816399765cd83db319989a1c995a3d |
| publicationDate | 2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-02076174-A2 |
| titleOfInvention | Fbh58295fl, a novel human amino acid transporter and uses thereof |
| abstract | The invention provides isolated nucleic acid molecules, designated HAAT nucleic acid molecules, which encode novel phospholipid transporter family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing HAAT nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a HAAT gene has been introduced or disrupted. The invention still further provides isolated HAAT proteins, fusion proteins, antigenic peptides and anti-HAAT antibodies. Diagnostic methods utilizing compositions of the invention are also provided. |
| priorityDate | 2001-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1092.